Bravecto Flea Treatment for Dogs: Complete Prescription Guide
Complete guide to Bravecto flea treatment for dogs — dosage, side effects, safety data, cost, and how this 12-week prescription parasiticide works.
What Is Bravecto and What Is It Used For in Dogs?
Bravecto is a branded parasiticide manufactured by Merck Animal Health containing the active ingredient fluralaner. It belongs to the isoxazoline drug class — the same family that includes NexGard (afoxolaner), Simparica (sarolaner), and Credelio (lotilaner). Unlike monthly oral preventives, Bravecto's distinguishing feature is its extended duration: a single chewable tablet provides up to 12 weeks (84 days) of continuous protection against fleas and several tick species.
FDA-approved veterinary uses for Bravecto chewable tablets in dogs include:
- Flea treatment and prevention — kills adult fleas (Ctenocephalides felis) and prevents flea infestations for 12 weeks
- Tick treatment and control — effective against black-legged tick (Ixodes scapularis), American dog tick (Dermacentor variabilis), and brown dog tick (Rhipicephalus sanguineus) for 12 weeks
- Lone Star tick (Amblyomma americanum) — control for 8 weeks (not the full 12)
- Treatment and control of sarcoptic mange (Sarcoptes scabiei) — effective as a single dose
Common off-label uses your veterinarian may discuss include treatment of demodectic mange (Demodex canis) and as part of a multimodal protocol for flea allergy dermatitis (FAD) management. While the FDA label does not specifically include these indications, published veterinary dermatology literature supports fluralaner's efficacy against Demodex mites, and many veterinary dermatologists prescribe it for this purpose.
How Does Bravecto Work? Mechanism of Action Explained
Mechanism of Action
Fluralaner works by inhibiting ligand-gated chloride channels in the arthropod nervous system — specifically targeting GABA-gated and glutamate-gated chloride channels. When a flea or tick bites your dog and ingests blood containing fluralaner, these channels are blocked, causing uncontrolled neural excitation, paralysis, and death of the parasite.
Key pharmacokinetic facts:
- Absorption: Fluralaner is absorbed systemically after oral administration, with peak plasma concentrations reached within 2–4 hours
- Half-life: Approximately 15 days in dogs — this long half-life is what enables the 12-week dosing interval
- Elimination: Primarily excreted unchanged in feces (~65%) with minor urinary excretion
- Onset of flea kill: Begins within 2 hours; >98% of fleas killed within 12 hours of administration
- Tick kill: Begins within 12 hours; >99% efficacy against target tick species within 48 hours
An important distinction for dog owners to understand: Bravecto does not repel parasites. Your dog may still have fleas or ticks attach and begin to bite before they die. However, because the parasites are killed before they can lay viable eggs, environmental flea populations collapse within one to two dosing cycles. For dogs with severe flea allergy dermatitis, your vet may recommend combining Bravecto with a short-term capstar (nitenpyram) treatment for immediate adult flea knockdown while fluralaner levels reach full efficacy.
Bravecto Dosage Chart by Dog Weight
Bravecto chewable tablets are available in five weight-specific formulations. Your veterinarian will prescribe the correct strength based on your dog's current body weight. The target dosage is approximately 25–56 mg/kg (11.4–25.4 mg/lb) of fluralaner per dose, administered orally once every 12 weeks.
| Dog Weight Range | Tablet Strength | Fluralaner Content (mg) | Approximate mg/kg Dose |
|---|---|---|---|
| 4.4 – 9.9 lb (2 – 4.5 kg) | Bravecto 112.5 | 112.5 mg | ~25–56 mg/kg |
| 9.9 – 22 lb (4.5 – 10 kg) | Bravecto 250 | 250 mg | ~25–56 mg/kg |
| 22 – 44 lb (10 – 20 kg) | Bravecto 500 | 500 mg | ~25–56 mg/kg |
| 44 – 88 lb (20 – 40 kg) | Bravecto 1000 | 1000 mg | ~25–56 mg/kg |
| 88 – 123 lb (40 – 56 kg) | Bravecto 1400 | 1400 mg | ~25–56 mg/kg |
Administration instructions: Bravecto chewable tablets should be given with food or shortly after a meal. Fluralaner is lipophilic, and administering the tablet with food significantly improves systemic absorption. The tablet is flavored (pork liver) and most dogs accept it readily. Do not break or split tablets — if your dog falls between weight categories, your veterinarian will prescribe the appropriate dose, which may involve combining tablet strengths.
Frequency: One dose every 12 weeks (84 days) for flea and tick prevention. For sarcoptic mange treatment, a single dose is typically curative, though your vet may recommend a follow-up skin scraping at 4 weeks to confirm resolution. For demodectic mange (off-label), protocols vary — some dermatologists recommend dosing every 4–8 weeks initially, then transitioning to the standard 12-week interval once mite counts normalize.
Side Effects: What the Clinical Data Shows
Bravecto has been administered to millions of dogs since its FDA approval in 2014. The safety profile has been extensively studied in both pre-approval field trials and post-market surveillance. According to Merck Veterinary Manual, the most commonly reported adverse events are gastrointestinal in nature and generally self-limiting.
| Side Effect | Reported Frequency | Typical Duration |
|---|---|---|
| Vomiting | ~1.7% | Usually within 24 hours of dosing |
| Decreased appetite | ~1.4% | 1–2 days |
| Diarrhea | ~1.3% | 1–3 days |
| Lethargy | ~0.9% | Usually resolves within 24 hours |
| Flatulence | ~0.5% | 1–2 days |
| Polydipsia (increased thirst) | <0.5% | Variable |
🚨 Serious Side Effects Requiring Immediate Veterinary Attention
The isoxazoline drug class, including fluralaner, carries an FDA advisory regarding neurologic adverse events. While rare, the following symptoms warrant an immediate call to your veterinarian or emergency clinic:
- Muscle tremors or twitching — especially if persistent or worsening
- Ataxia (loss of coordination) — stumbling, wobbling, inability to stand
- Seizures — both generalized and focal seizure activity have been reported
- Acute collapse or profound lethargy beyond typical mild drowsiness
The FDA issued a safety alert in September 2018 regarding neurologic events associated with isoxazoline-class drugs. The incidence rate is low — estimated at fewer than 1 in 10,000 doses — but dogs with a pre-existing seizure disorder or history of neurologic disease should generally not receive fluralaner. Discuss alternative parasiticide options with your veterinarian if your dog has any neurologic history.
Contraindications: Dogs Who Should NOT Receive Bravecto
While Bravecto has a broad safety margin, certain dogs should not receive this medication or require careful risk-benefit evaluation by your veterinarian:
- Puppies under 6 months of age — Bravecto is not approved for dogs younger than 6 months. For younger puppies, ask your vet about age-appropriate alternatives like Capstar or Frontline Plus.
- Dogs under 4.4 lb (2 kg) — The lowest tablet strength is formulated for dogs starting at 4.4 lb. Toy breeds below this threshold need alternative protocols.
- Dogs with known hypersensitivity to fluralaner — Any prior allergic reaction to Bravecto or other isoxazolines is an absolute contraindication.
- Dogs with a history of seizures or epilepsy — The FDA neurologic advisory applies. Your vet may prefer a non-isoxazoline parasiticide such as a topical pyrethroid (e.g., Vectra 3D) or a spinosad-class drug (Comfortis).
- Dogs with significant hepatic impairment — Because fluralaner is metabolized primarily by the liver, dogs with severe liver disease may have altered drug clearance. Your vet will evaluate liver enzyme panels before prescribing.
Pregnancy and lactation: Bravecto has been evaluated in breeding, pregnant, and lactating dogs at up to 3× the recommended dose with no adverse reproductive effects observed. It is considered safe for use in intact breeding females, but your veterinarian should still be informed of pregnancy status.
Drug Interactions to Discuss With Your Veterinarian
Drug Interaction Grid
| Concurrent Medication | Interaction Risk | Recommendation |
|---|---|---|
| Phenobarbital / potassium bromide (anti-seizure) | Hepatic enzyme induction may alter fluralaner metabolism; additive neurologic risk | Avoid isoxazolines; choose topical alternative |
| NSAIDs (carprofen, meloxicam, grapiprant) | No clinically significant interaction reported | Safe to co-administer; monitor GI signs |
| Heartworm preventives (ivermectin, milbemycin, moxidectin) | No clinically significant interaction at labeled doses | Safe to co-administer; many vets prescribe both concurrently |
| Corticosteroids (prednisone, dexamethasone) | Theoretical hepatic interaction with chronic use | Monitor liver values if long-term steroid use |
| Other isoxazolines (NexGard, Simparica, Credelio) | Duplicate therapy — risk of overdose | Never combine; choose one isoxazoline product only |
| Amitraz-containing collars (Preventic) | No direct pharmacologic interaction, but redundant tick coverage | Generally unnecessary; discuss with vet |
Always provide your veterinarian with a complete medication list — including over-the-counter supplements, topical products, and any medications prescribed by a different clinic — before starting Bravecto. This is especially critical if your dog sees a veterinary dermatologist or neurologist in addition to your primary care vet.
How Long Does My Dog Need to Be on Bravecto?
The duration of Bravecto treatment depends entirely on your geographic location and your veterinarian's parasite prevention protocol:
Year-round endemic areas (Southeastern US, Gulf Coast, Southern California, and most tropical/subtropical regions): Continuous year-round administration is recommended. This means four doses per year, every 12 weeks without interruption. Fleas remain active year-round in these climates, and tick-borne diseases like Lyme, ehrlichiosis, and anaplasmosis pose constant risk.
Seasonal risk areas (Northern US, Canada, mountain regions): Many veterinarians in these areas still recommend year-round prevention because indoor environments maintain flea populations even in winter. However, if your vet supports seasonal dosing, you would typically administer Bravecto from early spring (March–April) through late fall (November), covering approximately three doses per year.
Treatment of active infestations: If your dog already has a flea infestation, expect to administer at least two consecutive doses (covering 24 weeks) to fully break the flea life cycle. Environmental treatment of your home (vacuuming, washing bedding, potentially professional pest control for severe cases) should be done concurrently.
Mange treatment: For sarcoptic mange, a single dose is often curative. Your vet will typically schedule a follow-up skin scraping at 4 weeks post-treatment to confirm mite elimination. Demodectic mange may require a longer protocol — sometimes 2–4 months of treatment with monitoring via deep skin scrapings every 2–4 weeks until two consecutive negative results.
Monitoring Requirements and Follow-Up
Monitoring Schedule
| Scenario | Monitoring Action | Timing |
|---|---|---|
| Routine prevention (healthy dog) | Annual wellness exam; no additional bloodwork required specifically for Bravecto | Annually |
| Dog with liver disease | Hepatic panel (ALT, AST, ALP, bilirubin, bile acids) | Baseline + every 3–6 months |
| Sarcoptic mange treatment | Skin scraping to confirm mite elimination | 4 weeks post-dose |
| Demodectic mange (off-label use) | Deep skin scrapings; monitor for secondary bacterial pyoderma | Every 2–4 weeks until 2 consecutive negatives |
| Any dog with adverse reaction history | Neurologic exam; consider switching parasiticide class | Within 48 hours of reaction; before next dose |
For most healthy dogs on routine Bravecto prevention, no special monitoring beyond your standard annual wellness visit is needed. However, if your dog has pre-existing conditions or you observe any unusual symptoms after dosing, prompt veterinary follow-up is essential.
Cost Breakdown and Availability
Bravecto is available exclusively through licensed veterinarians and verified online pharmacies that require a valid prescription (such as Chewy Pharmacy, 1-800-PetMeds, and VetRxDirect). As of 2026, here is what you can expect to pay:
- Single chewable tablet (one dose): $45–$65 depending on weight tier
- Two-pack (6 months supply): $85–$125
- Annual cost (4 doses): $180–$260 per year
The larger weight tiers (88–123 lb) command the highest per-tablet price. Dogs over 123 lb require multiple tablets per dose — your vet will calculate the combination, which increases cost proportionally.
Generic availability: As of early 2026, fluralaner does not yet have a widely available generic equivalent in the US market. Merck Animal Health holds the primary patent, though patent timelines suggest generic entry may become possible in the late 2020s. No authorized generic is currently marketed.
Cost comparison to alternatives: While Bravecto's per-dose price is higher than some monthly options, the annual cost is competitive because you only purchase four doses instead of twelve. For comparison, NexGard (monthly afoxolaner) typically costs $18–$25 per month ($216–$300/year), and Simparica Trio (monthly, includes heartworm) runs $25–$35/month ($300–$420/year). When your dog needs heartworm prevention separately, a Bravecto + Heartgard combination often costs less annually than Simparica Trio alone.
Missed Doses, Overdose, and Emergency Protocol
If you miss a dose: Administer the tablet as soon as you remember, then restart the 12-week interval from that new date. For example, if dose was due March 1 but you remember March 15, give the tablet March 15 and schedule the next dose for June 7 (12 weeks from March 15). Do not double-dose to "catch up." During the gap in coverage, your dog may be vulnerable to flea and tick attachment — check your dog thoroughly and consider a Capstar dose for immediate flea knockdown if you observe active fleas.
If an overdose occurs: In safety studies, dogs received fluralaner at up to 5× the recommended dose without serious adverse effects. However, if your dog accidentally consumes multiple tablets (for example, a small dog ingests a tablet meant for a large dog), contact your veterinarian or the ASPCA Animal Poison Control Center at (888) 426-4435 (24/7, consultation fee applies) immediately. Monitor for vomiting, tremors, ataxia, or seizures. Do not attempt to induce vomiting at home unless specifically instructed by a veterinary professional.
📞 Emergency Contacts
- Your primary veterinarian or nearest emergency clinic — first call for any acute reaction
- ASPCA Animal Poison Control: (888) 426-4435 — 24/7, consultation fee applies
- Pet Poison Helpline: (855) 764-7661 — 24/7, consultation fee applies
Are There Alternatives to Bravecto?
Several effective alternatives exist within and outside the isoxazoline class. Your choice depends on your dog's health history, your dosing preference, and your budget:
| Product | Active Ingredient | Dosing Interval | Key Differences |
|---|---|---|---|
| NexGard | Afoxolaner (isoxazoline) | Monthly | Approved for puppies ≥8 weeks; monthly dosing may suit dogs with irregular schedules |
| Simparica | Sarolaner (isoxazoline) | Monthly | Approved for puppies ≥6 months; slightly different tick spectrum |
| Credelio | Lotilaner (isoxazoline) | Monthly | Must be given within 12 hours of feeding; approved for puppies ≥8 weeks |
| Vecta 3D (topical) | Dinotefuran/permethrin/pyriproxyfen | Monthly | Repels AND kills; non-isoxazoline option for dogs with seizure history. TOXIC TO CATS. |
| Seresto collar | Imidacloprid/flumethrin | Up to 8 months | Non-oral option; repels ticks; cost-effective for long-term use; contact dermatitis possible |
If your dog has a seizure disorder and isoxazolines are contraindicated, the Seresto collar or Vectra 3D topical are the most commonly recommended alternatives. Discuss the full risk-benefit profile with your veterinarian, as no parasiticide is universally ideal for every dog.
Frequently Asked Questions
Can I give Bravecto to my dog if they're on heartworm prevention?
Yes. Bravecto does not contain a heartworm preventive ingredient, so it is commonly prescribed alongside heartworm medications such as Heartgard Plus (ivermectin/pyrantel), Interceptor Plus (milbemycin/praziquantel), or Revolution Plus (selamectin/sarolaner). There are no clinically significant drug interactions between fluralaner and these macrocyclic lactone-based preventives at labeled doses. Many veterinarians actually prefer this separation because it allows individualized adjustment of flea/tick and heartworm protocols independently.
Does Bravecto protect against mosquitoes or heartworm?
No. Bravecto does not repel or kill mosquitoes, and it provides zero heartworm prevention. You will need a separate heartworm preventive medication. This is actually a feature some owners prefer — if your dog has an adverse reaction, you and your vet can more easily identify which product caused it.
My dog vomited shortly after taking Bravecto. Should I re-dose?
If vomiting occurs within 2 hours of administration, a significant portion of the dose may not have been absorbed. Contact your veterinarian — they will typically recommend re-dosing with a new tablet. If vomiting occurs more than 2 hours after dosing, sufficient absorption has likely occurred and re-dosing is usually unnecessary. Always call your vet to confirm rather than making this decision independently.
Is Bravecto safe for MDR1-sensitive breeds like Collies and Australian Shepherds?
The MDR1 (ABCB1) gene mutation affects the blood-brain barrier's ability to pump certain drugs out of the central nervous system. While ivermectin is the classic concern for MDR1-mutant dogs, fluralaner is not a substrate for the P-glycoprotein pump affected by this mutation. According to the Washington State University Veterinary Clinical Pharmacology Laboratory, isoxazolines including fluralaner are generally considered safe for MDR1-mutant dogs at labeled doses. However, always inform your veterinarian if your dog has a known MDR1 mutation or is a breed commonly affected (Collie, Australian Shepherd, Shetland Sheepdog, Longhaired Whippet).
Can Bravecto be used with flea shampoos or sprays?
Topical flea shampoos and sprays can be used alongside oral Bravecto without pharmacologic interaction, since fluralaner works systemically through the bloodstream rather than topically on the skin. However, most topical flea sprays are unnecessary if your dog is on effective oral prevention. If you're dealing with an active environmental infestation, focus your efforts on treating the home (vacuuming, washing all bedding in hot water, treating carpets with an insect growth regulator like methoprene) rather than adding redundant topical products to your dog.
How does Bravecto compare to Bravecto topical for dogs?
Merck also produces a Bravecto topical solution for dogs, which is applied to the skin between the shoulder blades. The topical formulation contains the same active ingredient (fluralaner) and provides the same 12-week duration. The oral chewable is generally preferred because it avoids application-site reactions and bathing restrictions (you should avoid bathing your dog for 48 hours after topical application). However, the topical version is useful for dogs that refuse oral medications or have conditions affecting oral drug absorption.
Marcus Aldridge
All our authors care for dogs every day — read more of their work on the authors page.
